Persones / Equip Humà

Antoni Noguera Julián

Buscador de publicacions

Publicacions

  • Judd A.

    Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens

    Aids . 25(18): 2279-2287. Nº de cites: 40

    [doi:10.1097/QAD.0b013e32834d614c]

  • Morén C, Noguera-Julián A, Rovira N, Corrales E, Garrabou G, Hernández S, Nicolás M, Tobías E, Cardellach F, Miró O and Fortuny-Guasch C.

    MITOCHONDRIAL IMPACT OF HUMAN IMMUNODEFICIENCY VIRUS AND ANTIRETROVIRALS ON INFECTED PEDIATRIC PATIENTS WITH OR WITHOUT LIPODYSTROPHY

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 30(11): 992-995. Nº de cites: 13

    [doi:10.1097/INF.0b013e3182253c54]

  • Claret-Teruel G, Noguera-Julián A, Esteva-Afonso C, Munoz-Almagro C, Sánchez E, Jiménez R and Fortuny-Guasch C.

    IMPACT OF HUMAN IMMUNODEFICIENCY VIRUS COINFECTION ON THE PROGRESSION OF MOTHER-TO-CHILD TRANSMITTED HEPATITIS C VIRUS INFECTION

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 30(9): 801-804. Nº de cites: 10

    [doi:10.1097/INF.0b013e3182196ab4]

  • Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julián A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G and Phillips A.

    Risk of triple-class virological failure in children with HIV: a retrospective cohort study

    Lancet . 377(9777): 1580-1587. Nº de cites: 95

    [doi:10.1016/S0140-6736(11)60208-0]

  • Fortuny-Guasch C, Noguera-Julián A, Alsina L, Bellido R, Sánchez E, Munoz-Almagro C, Ruiz L and Jiménez R.

    IMPACT OF CD4 T CELL COUNT ON THE OUTCOME OF PLANNED TREATMENT INTERRUPTIONS IN EARLY-TREATED HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 30(5): 435-438. Nº de cites: 9

    [doi:10.1097/INF.0b013e3181ff8661]

  • Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D and Chêne G.

    Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    LANCET INFECTIOUS DISEASES . 11(5): 363-371. Nº de cites: 318

    [doi:10.1016/S1473-3099(11)70032-9]

  • Noguera-Julián A, Provens AC, Soler-Palacín P, Espiau M, Mur A, Méndez M and Fortuny-Guasch C.

    PANDEMIC INFLUENZA A (2009 H1N1) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CATALAN CHILDREN

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 30(2): 173-175. Nº de cites: 6

    [doi:10.1097/INF.0b013e3181f5358b]

  • Morén C, Noguera-Julián A, Rovira N, Garrabou G, Nicolàs M, Cardellach F, Martínez E, Sánchez E, Miró O and Fortuny-Guasch C.

    Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART

    ANTIVIRAL THERAPY . 16(5): 719-724. Nº de cites: 7

    [doi:10.3851/IMP1806]

  • Soler-Palacín P, Melendo S, Noguera-Julián A, Fortuny-Guasch C, Navarro ML, Mellado MJ, Garcia L, Uriona S, Martín-Nalda A and Figueras C.

    Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens

    Aids . 25(2): 171-176. Nº de cites: 32

    [doi:10.1097/QAD.0b013e328340fdca]

  • Noguera-Julián A, Morén C, Rovira N, Sànchez E, Garrabou G, Nicolàs M, Munoz-Almagro C, Cardellach F, Miró O and Fortuny-Guasch C.

    Evolution of Mitochondrial DNA Content After Planned Interruption of HAART in HIV-Infected Pediatric Patients

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 26(9): 1015-1018. Nº de cites: 6

    [doi:10.1089/aid.2009.0273]